Video-Assisted Thoracoscopic Lobectomy Is the Preferred Approach Following Induction Chemotherapy

被引:38
作者
Kamel, Mohamed K. [1 ]
Nasar, Abu [1 ]
Stiles, Brendon M. [1 ]
Altorki, Nasser K. [1 ]
Port, Jeffrey L. [1 ]
机构
[1] New York Presbyterian Hosp, Weill Cornell Med, Dept Cardiothorac Surg, Div Thorac Surg, New York, NY USA
来源
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES | 2017年 / 27卷 / 05期
关键词
VATS; lobectomy; induction therapy; NSCLC; TYROSINE KINASE INHIBITORS; CELL LUNG-CANCER; RANDOMIZED CONTROLLED-TRIALS; LONG-TERM SURVIVAL; THORACIC-SURGERY; THORACOTOMY; THERAPY; METAANALYSIS; DATABASE; VATS;
D O I
10.1089/lap.2016.0540
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: A video-assisted thoracoscopic surgical (VATS) resection, after induction chemotherapy, has long been considered a relative contraindication. We report our experience with VATS lobectomy after induction chemotherapy for patients with nonsmall cell lung cancer (NSCLC), with propensity-matched group of patients, who underwent an open approach, to determine safety and oncological outcome. Methods: A retrospective review of a prospective database (2002-2014) was performed to identify patients undergoing potentially curative lobectomy for NSCLC after induction therapy. Propensity score matching (age, gender, and clinical stage) was performed (1: 2) to obtain a balanced cohort of patients undergoing VATS resection and thoracotomy. Results: A total of 285 patients underwent lobectomy after induction therapy, 114 were propensity matched (VATS, n= 40, thoracotomy, n= 74). There were no differences in the clinicopathological factors or type of induction therapy (conventional versus targeted) between VATS and thoracotomy groups. Similarly, no differences were found in the number of lymph nodes resected (12 versus 15, P=.94), the number of stations sampled (4 for each, P=.68), or in the rate of R0 resection (95% versus 96%, P=.81) between VATS and thoracotomy groups. Five VATS cases were converted to an open approach because of adhesions. VATS resection was associated with less estimated blood loss (EBL), shorter length of stay (LOS), and a trend toward fewer postoperative complications. There was no difference in 5 years disease-free survival (DFS) between VATS and thoracotomy groups (73% versus 48%, P=.09). Similarly, for patients who presented with cN2, there were no differences between thoracotomy and VATS groups in DFS (P=.37). On multi-variable analysis (MVA), only the clinical N1/2 status [Hazard ratio (HR): 4.86, P<.001] independently predicted poor DFS. Conclusions: A VATS lobectomy is a feasible, safe, and oncologically sound approach after induction therapy for NSCLC. When compared with thoracotomy, VATS lobectomy is associated with lower EBL, shorter LOS, and a trend toward fewer postoperative complications.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 17 条
[1]   Role of tyrosine kinase inhibitors in cancer therapy [J].
Arora, A ;
Scholar, EM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :971-979
[2]   Extended minimally invasive lung resections: VATS bilobectomy, bronchoplasty, and pneumonectomy [J].
Augustin, Florian ;
Maier, Herbert ;
Lucciarini, Paolo ;
Bodner, Johannes ;
Klotzner, Stephan ;
Schmid, Thomas .
LANGENBECKS ARCHIVES OF SURGERY, 2016, 401 (03) :341-348
[3]   Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer [J].
Flores, Raja M. ;
Park, Bernard J. ;
Dycoco, Joseph ;
Aronova, Anna ;
Hirth, Yael ;
Rizk, Nabil P. ;
Bains, Manjit ;
Downey, Robert J. ;
Rusch, Valerie W. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (01) :11-18
[4]   Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: A systematic review and meta-analysis of randomized controlled trials [J].
Funakoshi, Tomohiro ;
Latif, Asma ;
Gasky, Matthew D. .
CANCER TREATMENT REVIEWS, 2014, 40 (05) :636-647
[5]   Contraindications of video-assisted thoracoscopic surgical lobectomy and determinants of conversion to open [J].
Hanna, Jennifer M. ;
Berry, Mark F. ;
D'Amico, Thomas A. .
JOURNAL OF THORACIC DISEASE, 2013, 5 :S182-S189
[6]   Feasibility of complete video-assisted thoracoscopic surgery following neoadjuvant therapy for locally advanced non-small cell lung cancer [J].
Huang, Jun ;
Xu, Xin ;
Chen, Hanzhang ;
Yin, Weiqiang ;
Shao, Wenlong ;
Xiong, Xinguo ;
He, Jianxing .
JOURNAL OF THORACIC DISEASE, 2013, 5 :S267-S273
[7]   Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy [J].
Lee, Paul C. ;
Kamel, Mohamed ;
Nasar, Abu ;
Ghaly, Galal ;
Port, Jeffrey L. ;
Paul, Subroto ;
Stiles, Brendon M. ;
Andrews, Weston G. ;
Altorki, Nasser K. .
ANNALS OF THORACIC SURGERY, 2016, 101 (03) :1116-1122
[8]   Long-Term Survival After Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery Versus Thoracotomy [J].
Lee, Paul C. ;
Nasar, Abu ;
Port, Jeffrey L. ;
Paul, Subroto ;
Stiles, Brendon ;
Chiu, Ya-Lin ;
Andrews, Weston G. ;
Altorki, Nasser K. .
ANNALS OF THORACIC SURGERY, 2013, 96 (03) :951-961
[9]   Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer [J].
Passaro, Antonio ;
Cortesi, Enrico .
TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (04) :280-282
[10]   Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database [J].
Paul, Subroto ;
Sedrakyan, Art ;
Chiu, Ya-lin ;
Nasar, Abu ;
Port, Jeffrey L. ;
Lee, Paul C. ;
Stiles, Brendon M. ;
Altorki, Nasser K. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (04) :813-817